je.st
news
Dyax Corp. Stock Rating Upgraded by Vetr Inc.
2015-06-07 01:23:38| Biotech - Topix.net
The firm currently has a $25.05 target price on the biopharmaceutical company's stock. Vetr 's price objective points to a potential downside of 1.65% from the stock's previous close.
Tags: inc
rating
stock
corp
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||